Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

Autor: Gimbel, Marieke, Qaderdan, Khalid, Willemsen, Laura, Hermanides, Rik, Bergmeijer, Thomas, de Vrey, Evelyn, Heestermans, Ton, Tjon Joe Gin, Melvyn, Waalewijn, Reinier, Hofma, Sjoerd, den Hartog, Frank, Jukema, Wouter, von Birgelen, Clemens, Voskuil, Michiel, Kelder, Johannes, Deneer, Vera, ten Berg, Jurriën ^*

Publikováno v: In The Lancet 25 April-1 May 2020 395(10233):1374-1381

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older—rationale and design of the POPular AGE study

Autor: Qaderdan, Khalid, Ishak, Maycel, Heestermans, Antonius A.C.M., de Vrey, Evelyn, Jukema, J. Wouter, Voskuil, Michiel, de Boer, Menko-Jan, van‘t Hof, Arnoud W.J., Groenemeijer, Björn E., Vos, Gerrit-Jan A., Janssen, Paul W.A., Bergmeijer, Thomas O., Kelder, Johannes C., Deneer, Vera H.M., ten Berg, Jurriën M.

Publikováno v: In American Heart Journal November 2015 170(5):981-985

Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study

Autor: Janssen, Paul W.A., Bergmeijer, Thomas O., Vos, Gert Jan A., Kelder, Johannes C., Qaderdan, Khalid, Godschalk, Thea C., Breet, Nicoline J., Deneer, Vera H.M., Hackeng, Christian M., ten Berg, Jurriën M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: European Journal of Clinical Pharmacology, 75(9), 1201. Springer
European Journal of Clinical Pharmacology, 75(9), 1201. Springer Verlag

PURPOSE: The POPular Risk Score was developed for the selective intensification of P2Y 12 inhibitor treatment with prasugrel instead of clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI) with stent implantation. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d211269ebfd09dbd8272d71fe64ec7b
https://dspace.library.uu.nl/handle/1874/391926

Tailored P2Y 12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study.

Autor: Janssen PWA; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands. p.janssen@antoniusziekenhuis.nl.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands. p.janssen@antoniusziekenhuis.nl., Bergmeijer TO; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands., Vos GA; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands., Kelder JC; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands., Qaderdan K; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands., Godschalk TC; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands., Breet NJ; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands.; Department of Cardiology, Gelre ziekenhuizen, Apeldoorn, The Netherlands., Deneer VHM; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Hackeng CM; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands.; Department of Clinical Chemistry, St Antonius Hospital, Nieuwegein, The Netherlands., Ten Berg JM; Department of Cardiology, St Antonius Hospital, P/O Box 2500, 3432 EM, Nieuwegein, The Netherlands.; St Antonius Centre for Platelet Function Research, St Antonius Hospital, Nieuwegein, The Netherlands.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2019 Sep; Vol. 75 (9), pp. 1201-1210. Date of Electronic Publication: 2019 Jun 14.